Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 EUR | 0.00% | -1.66% | -20.86% |
Mar. 27 | Heidelberg Pharma Wins US FDA Orphan Drug Designation for Multiple Myeloma Treatment | MT |
Mar. 25 | Transcript : Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024 |
- Stock Market
- Equities
- HPHA Stock
- News Heidelberg Pharma AG